At 7.7% CAGR, Europe Vegetarian Capsules Market is Projected to be Worth US$ 875.20 Million by 2031, says Business Market Insights

According to Business Market Insights' research, the Europe vegetarian capsules market was valued at US$ 481.73 million in 2023 and is expected to reach US$ 875.20 million by 2031, registering a CAGR of 7.7% from 2023 to 2031. Innovative product launches of vegetarian capsules and outsourcing of vegetarian capsules are among the critical factors attributed to drive the Europe vegetarian capsules market growth.

Innovation in vegetarian capsule products is of utmost importance for manufacturers to promote it as the best alternative to gelatin capsules. Nutraceutical companies are launching modified-release vegetarian capsules for effective drug absorption and to achieve predetermined clinical objectives.

"DRcaps capsules" by Lonza's (Capsugel) are vegetarian capsules manufactured using hydroxypropyl methylcellulose (HPMC), which disintegrates more slowly than traditional gelatin capsules. Such HPMC-derived vegetarian capsules keep the ingredients intact in the capsule shell. Also, DRcaps capsules do not require any external application of chemical coatings to keep the ingredients intact, mask taste, or postpone the release of the active ingredients, proving advantageous for consumers who doubt capsule coatings as "unnatural." The clinical in-vitro studies on DRcaps capsules reveal that the capsule contents are intact for at least 30 minutes, with a gastric pH of 1.2, and disintegrate fully at an intestinal pH of 6.8. The DRcaps capsules are modified-release vegetarian capsule types that benefit consumers dealing with bad taste or aftertaste caused by some ingredients. Further, these capsules can eliminate certain disintegration steps such as coating, which reduces high production costs and time.

Several nutraceutical manufacturers are developing acid-resistant vegetarian capsules as probiotics cannot travel through stomach acid. Several probiotic products contain "strains" that cannot survive the passage of stomach acid. The SILVACO company's "Acid-Resistant vegetable HPMC capsules" can pass through the stomach acid, travel in low-pH environments, and quickly disintegrate in the intestinal tract.

Vegetarian capsule manufactures are developing innovative products to obtain predetermined clinical objectives and gain a significant advantage over gelatin capsules, which is expected to offer lucrative opportunities for the vegetarian capsules market during the forecast period.

On the contrary, risks of product recalls hamper the growth of Europe vegetarian capsules market.

Based on product, the Europe vegetarian capsules market is segmented hydroxypropyl methylcellulose (HPMC), pullulan, and others. The hydroxypropyl methylcellulose (HPMC) segment held 77.0% market share in 2023, amassing US$ 370.99 million. It is projected to garner US$ 668.47 million by 2031 to register 7.6% CAGR during 2023-2031.

In terms of application, the Europe vegetarian capsules market is categorized into antibiotic and antibacterial drug, vitamin and dietary supplement, anti-inflammatory drugs, cardiovascular therapy drugs, antacid and antiflatulent preparation, and others. The antibiotic and antibacterial drug segment held 39.3% share of Europe vegetarian capsules market in 2023, amassing US$ 189.37 million. It is anticipated to garner US$ 348.54 million by 2031 to expand at 7.9% CAGR during 2023-2031.

By functionality, the Europe vegetarian capsules market is segmented into immediate release capsules, sustained release capsules, and delayed release capsules. The immediate release capsules segment held 55.0% market share in 2023, amassing US$ 264.74 million. It is projected to garner US$ 462.91 million by 2031 to register 7.2% CAGR during 2023-2031.

By end user, the Europe vegetarian capsules market is segmented into pharmaceutical companies, nutraceutical companies, contract manufacturing organizations (CMOS), and cosmeceutical companies. The pharmaceutical companies segment held 58.4% market share in 2023, amassing US$ 281.47 million. It is projected to garner US$ 526.51 million by 2031 to register 8.1% CAGR during 2023-2031.

By country, the Europe vegetarian capsules market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that the UK captured 28.3% share of Europe vegetarian capsules market in 2023. It was assessed at US$ 136.14 million in 2023 and is likely to hit US$ 243.83 million by 2031, registering a CAGR of 7.6% during 2023-2031.

Key players operating in the Europe vegetarian capsules market are ACG; CapsCanada; Capsugel, Inc (A subsidiary of Lonza Group AG); HealthCaps India; Lefancaps; NATURAL CAPSULES LIMITED; QUALICAPS; Shanxi Guangsheng Medicinal Capsules Co (GS Capsules); BrightCaps GmbH; Sunil Healthcare Limited; Yasin; Zhejiang Honghui Capsule Co., Ltd; and Zhejiang Huili Capsules Co., Ltd., among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com